Health on MSN11d
How Is Metabolic Dysfunction-Associated Steatohepatitis (MASH) Diagnosed?
Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH) is a disease that occurs when ...
BioSpace11d
Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...
Pharmabiz3d
EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples
EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...
Tahoe Daily Tribune.com16d
Non-alcoholic fatty liver disease
However, steatosis can progress to nonalcoholic steatohepatitis ... with a liver biopsy being used when these less invasive tests are inconclusive. Summary and Conclusion Non-alcoholic fatty ...
NL Times4d
European Medicines Agency gives first green light to AI use citing liver biopsy trial
The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...
pharmaphorum4d
EMA panel endorses AI for MASH clinical trials
AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...
Medscape1mon
A Case of Persistent Anemia and Alcohol Abuse
Diagnosis: Alcohol-related anemia ... was diagnosed from a transjugular liver biopsy sample, which revealed micronodular cirrhosis with low-grade steatohepatitis. Bone-marrow aspiration was ...
Nature3mon
Nonalcoholic fatty liver disease: from pathogenesis to patient care
Liver biopsy is the only ... shift from steatosis to steatohepatitis are, however, unknown. Hypothetical mechanisms have been deduced from animal models and from alcohol-induced liver diseases ...